IRVINE, Calif.–(BUSINESS WIRE)–Sep. 15, 2016–
Masimo (NASDAQ:
MASI) announced today the findings of a study recently presented at the
World Congress of Anesthesiologists (WCA) in Hong Kong. In the study,
researchers at Cairo University in Egypt investigated the clinical
utility of a Masimo SET® noninvasive, continuous
measurement, PVI®.

In the prospective study of 60 adult patients undergoing major abdominal
surgery, Drs. Hafez and Helmy of Cairo University evaluated the
performance of Masimo PVI as a non-invasive guide to fluid optimization,
as compared to transesophageal doppler. Patients were divided into flu…

Más información: Study on Abdominal Surgical Patients Investigates Clinical Utility of Masimo PVI®